Silk Road Medical (NASDAQ:SILK) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.40) by 10 percent. This is a 16.28 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $48.484 million which beat the analyst consensus estimate of $44.676 million by 8.52 percent. This is a 20.81 percent increase over sales of $40.131 million the same period last year.